| 產(chǎn)品編號 | IHC0118H |
| 英文名稱 | Human ACE2 Ready-To-Use IHC Kit |
| 中文名稱 | 人血管緊張素轉(zhuǎn)換酶2即用型免疫組化試劑盒 |
| 性 狀 | Liquid |
| 種 屬 | Human |
| 應(yīng)用范圍 | Immunohistochemistry |
| 適用樣品基質(zhì) | FFPE tissue |
| 描述 | IHC0118H is a ready-to-use IHC kit for staining of human ACE2. The kit provides all reagents, from antigen retrieval to cover slip mounting, that require little to no diluting or handling prior to use. Simply apply the reagents to your sample slide according to the protocol and you're steps away from obtaining high-quality IHC data. Angiotensin converting enzyme 2 (ACE2) is an exopeptidase that catalyses the conversion of angiotensin I to the nonapeptide angiotensin[1-9], or the conversion of angiotensin II to angiotensin 1-7. ACE2 has direct effects on cardiac function,a and is expressed pred |
| 保存條件 | Please store components at the temperatures indicated on the individual tube labels. The kit is stable for 6 months from the date of receipt. |
| 注意事項(xiàng) | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
| 產(chǎn)品介紹 |
Angiotensin converting enzyme 2 (ACE2) is an exopeptidase that catalyses the conversion of angiotensin I to the nonapeptide angiotensin[1-9], or the conversion of angiotensin II to angiotensin 1-7. ACE2 has direct effects on cardiac function,a and is expressed predominantly in vascular endothelial cells of the heart and the kidneys. ACE2 is not sensitive to the ACE inhibitor drugs used to treat hypertension. ACE2 receptors have been shown to be the entry point into human cells for some coronaviruses, including the SARS virus[10]. A number of studies have identified that the entry point is the same for SARS-CoV-2, the COVID-19 virus. SWISS: Q9BYF1 Gene ID: 59272 |
| 產(chǎn)品圖片 |
Immunohistochemical analysis of paraffin embedded human kidney carcinoma tissue slide using IHC0118H (Human ACE2 IHC Kit).
Immunohistochemical analysis of paraffin embedded human kidney tissue slide using IHC0118H (Human ACE2 IHC Kit).
|
